Earnings Feed
Start Free
Home/Insiders/CROWELL NANCY M
CN
SEC Insider//CIK 0001210622

CROWELL NANCY M

CIK 00012106222 companiesLINCOLNSHIRE, IL
SEC Profile

Transactions

23

Companies

2

Filings

9

CIK

0001210622

Recent Transactions

23 trades
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−30,000→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy0

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy0

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Common Stock

    2009-10-14−8,000→ 0 total
  • Award
    CELL GENESYS INC

    Stock Option (Right to Buy)

    2007-06-29+7,500→ 7,500 total
  • Award
    CELL GENESYS INC

    Common Stock

    2007-06-29+4,000→ 4,000 total
  • Award
    RENOVIS INC

    Stock Option (right to buy)

    2007-01-26+11,111→ 11,111 total
  • Award
    CELL GENESYS INC

    Stock Option (Right to Buy)

    2006-06-30$5.02/sh+7,500→ 7,500 total
  • Award
    RENOVIS INC

    Stock Option (Right to buy)

    2006-01-16+11,111→ 11,111 total
  • Award
    CELL GENESYS INC

    Stock Option (right to buy)

    2005-06-30$5.35/sh+7,500→ 60,000 total
  • Sale
    RENOVIS INC

    Common Stock

    2005-05-09$15.47/sh−68→ 47,312 total
  • Award
    RENOVIS INC

    Stock Option (Right to buy)

    2005-02-09+11,111→ 11,111 total
  • Conversion
    RENOVIS INC

    Series C Preferred Stock

    2004-02-10−97,174→ 0 total
  • Conversion
    RENOVIS INC

    Series C Preferred Stock

    2004-02-10−1,607,647→ 0 total
  • Conversion
    RENOVIS INC

    Common Stock

    2004-02-10+47,380→ 47,380 total
  • Conversion
    RENOVIS INC

    Series E Preferred Stock

    2004-02-10−116,036→ 0 total
  • Conversion
    RENOVIS INC

    Series E Preferred Stock

    2004-02-10−1,919,678→ 0 total
  • Conversion
    RENOVIS INC

    Common Stock

    2004-02-10+783,850→ 783,850 total

Companies

2

Recent Filings

9

Address

C/O BIOSANTE PHARMACEUTICALS, INC. 111 BARCLAY BOULEVARD, SUITE 280

LINCOLNSHIRE, IL, 60069

View on SEC.gov